EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

3,4-Bis(benzyloxy)benzaldehyde-Derived Hydrazones: Synthesis, α-Amylase-Selective Inhibition, Antioxidant Profiling, and In Silico Evaluation

Hanifa Fatullayev, Ismail Celik, Leyla Paşayeva

ACS Omega · 19.11.2026

DOI: 10.1021/acsomega.6c07978 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 19.11.2026. Verfasst von Hanifa Fatullayev und 2 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bilimsel Arastirma Projeleri, Erciyes ?niversitesi.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbohydrate-hydrolyzing enzymes (α-amylase and α-glucosidase) are clinically validated targets for controlling postprandial hyperglycemia in type 2 diabetes mellitus (T2DM), and oxidative stress is a recognized contributor to disease progression. Herein, a series of hydrazone Schiff bases derived from 3,4-bis(benzyloxy)benzaldehyde were synthesized by acid-catalyzed condensation of the aldehyde with para-substituted phenylhydrazines and were characterized by 1H and 13C NMR spectroscopy, FT-IR spectroscopy, and high-resolution mass spectrometry; chromatographic purity was established by RP-HPLC (94.5–98.6 area % at 350 nm). The series was evaluated for in vitro inhibition of porcine pancreatic α-amylase and yeast α-glucosidase and for antioxidant capacity using four complementary assays (DPPH, ABTS, FRAP, and CUPRAC). The compounds displayed a pronounced α-amylase preference: compound 9 (IC50 = 160.40 ± 2.05 μg/mL) and compound 7 (IC50 = 166.01 ± 2.64 μg/mL) were the most potent and exceeded acarbose under the assay conditions (IC50 = 232.66 ± 4.93 μg/mL); on a molar basis, both are essentially equipotent with the reference drug (345.2 ± 4.4 and 378.6 ± 6.0 μM versus 360.4 ± 7.6 μM), and IC50 values are reported in both units throughout (Table 1). α-Glucosidase inhibition was moderate, with the para-chloro analogue 3 being the most active (IC50 = 83.13 ± 6.53 μg/mL; 187.7 ± 14.7 μM). The selectivity index (IC50 α-glucosidase/IC50 α-amylase) spans 0.22 for 3 to 2.38 for 9, so a single para-substituent determines which carbohydrase is preferred. Antioxidant behavior was assay-dependent: compounds 1 and 4 delivered the highest ferric-reducing power (FRAP = 1854.0 ± 1.5 and 1786.7 ± 5.2 μmol Fe2+/g), and compound 5 gave the strongest CUPRAC response (280.95 ± 3.43 mg GAE/g). Molecular docking against α-amylase (PDB 1B2Y) and α-glucosidase (PDB 3TOP), together with SwissADME, QikProp, and ADMETlab profiling, provides a structural rationale for the observed substituent effects. These results define a clear, substituent-driven selectivity relationship within a lipophilic dibenzyloxy hydrazone framework and establish the DBZO-hydrazone scaffold as a tractable system for further optimization.

Förderung

  • Bilimsel Arastirma Projeleri, Erciyes ?niversitesi

Zitieren

APA

Fatullayev, H., Celik, I., & Paşayeva, L. (2026). 3,4-Bis(benzyloxy)benzaldehyde-Derived Hydrazones: Synthesis, α-Amylase-Selective Inhibition, Antioxidant Profiling, and In Silico Evaluation. ACS Omega. https://doi.org/10.1021/acsomega.6c07978

Vancouver

Fatullayev H, Celik I, Paşayeva L. 3,4-Bis(benzyloxy)benzaldehyde-Derived Hydrazones: Synthesis, α-Amylase-Selective Inhibition, Antioxidant Profiling, and In Silico Evaluation. ACS Omega. 2026. doi:10.1021/acsomega.6c07978

BibTeX
@article{Fatullayev2026,
  author = {Fatullayev, Hanifa and Celik, Ismail and Paşayeva, Leyla},
  title = {3,4-Bis(benzyloxy)benzaldehyde-Derived Hydrazones: Synthesis, α-Amylase-Selective Inhibition, Antioxidant Profiling, and In Silico Evaluation},
  journal = {ACS Omega},
  year = {2026},
  doi = {10.1021/acsomega.6c07978}
}
Kostenlos starten →